Inventor · disambiguated record
Henry J. Breslin
Also filed as: BRESLIN HENRY · BRESLIN HENRY J · BRESLIN HENRY JOSEPH
37 granted patents·2 pending applications·253 citations·filing 1992–2018
97Inventor score
Files withJANSSEN PHARMACEUTICA NV18Atrin Pharmaceuticals LLC4CEPHALON INC3JANNSEN PHARMACEUTICA N V3AHMED GULZAR2
Top patents by PatentIndex Score
39 records- 0196US9700542B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jul 11, 2017·18 cites·19 claims
- 0296US7741356B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Jun 22, 2010·38 cites·43 claims
- 0395US7786158B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 31, 2010·23 cites·29 claims
- 0493US8772325B2Compounds as opioid receptor modulatorsJANNSEN PHARMACEUTICA N V·Filed 2013·Granted Jul 8, 2014·15 cites·23 claims
- 0593US8344011B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 1, 2013·17 cites·78 claims
- 0692US9205076B2Compounds as opioid receptor modulatorsJANNSEN PHARMACEUTICA N V·Filed 2014·Granted Dec 8, 2015·12 cites·24 claims
- 0792US8609709B2Compounds as opioid receptor modulatorsJANNSEN PHARMACEUTICA N V·Filed 2012·Granted Dec 17, 2013·11 cites·8 claims
- 0889US9663535B2Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitorsAtrin Pharmaceuticals LLC·Filed 2015·Granted May 30, 2017·9 cites·54 claims
- 0989US8148391B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitorsAHMED GULZAR·Filed 2007·Granted Apr 3, 2012·17 cites·8 claims
- 1085US8552186B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitorsAHMED GULZAR·Filed 2012·Granted Oct 8, 2013·10 cites·26 claims
- 1185US7943635B2Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 17, 2011·7 cites·9 claims
- 1285US7125891B2Tripeptidyl peptidase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Oct 24, 2006·18 cites·6 claims
- 1382US9914730B2Azaquinazoline inhibitors of Atypical protein Kinase CIGNYTA INC·Filed 2013·Granted Mar 13, 2018·6 cites·13 claims
- 1482US9896446B2Azaquinazoline inhibitors of atypical protein kinase CIGNYTA INC·Filed 2015·Granted Feb 20, 2018·4 cites·14 claims
- 1581US7241777B2Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 10, 2007·14 cites·8 claims
- 1676US7511061B2Triazoles as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Mar 31, 2009·2 cites·12 claims
- 1775US7947713B2Tripeptidyl peptidase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 24, 2011·1 cites·8 claims
- 1874US9487529B2Macrocyclic compounds as ALK, FAK and JAK2 inhibitorsCEPHALON INC·Filed 2013·Granted Nov 8, 2016·1 cites·22 claims
- 1973US8471005B2Pyrrolotriazines as ALK and JAK2 inhibitorsBRESLIN HENRY J·Filed 2011·Granted Jun 25, 2013·3 cites·10 claims
- 2071US9238656B2Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disordersCEPHALON INC·Filed 2014·Granted Jan 19, 2016·1 cites·28 claims
- 2170US8895573B2Phenoxy-substituted pyrimidines as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Nov 25, 2014·1 cites·3 claims
- 2269US7041681B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted May 9, 2006·3 cites·33 claims
- 2368US7049324B1Triazoles as farnesyl transferase inhibitorsSAHA ASHIS KUMAR·Filed 2000·Granted May 23, 2006·6 cites·10 claims
- 2467US10213415B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 26, 2019·0 cites·2 claims
- 2566US5270464AAnti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) onesJANSSEN PHARMACEUTICA NV·Filed 1993·Granted Dec 14, 1993·7 cites·11 claims
- 2658US7659402B2Piperidines as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 9, 2010·0 cites·1 claims
- 2757US7592356B2Triazoles as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 22, 2009·0 cites·10 claims
- 2857US5268373AGuanidine derivatives, compositions and useMCNEILAB INC·Filed 1992·Granted Dec 7, 1993·5 cites·15 claims
- 2956US9981989B2Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitorsAtrin Pharmaceuticals LLC·Filed 2017·Granted May 29, 2018·0 cites·28 claims
- 3056US7202381B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Apr 10, 2007·0 cites·7 claims
- 3155US2017027948A1Macrocyclic compounds as alk, fak and jak2 inhibitorsCEPHALON INC·Filed 2016·Application pending·0 cites
- 3254US2006276509A1Tripeptidyl peptidase inhibitorsBRESLIN HENRY J·Filed 2006·Application pending·0 cites
- 3353US5371079AAntiretroviral tetrahydroimidazo[1,4]benzodiazepin-2-(thi)onesJANSSEN PHARMACEUTICA NV·Filed 1993·Granted Dec 6, 1994·3 cites·10 claims
- 3452US10196405B2Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitorsAtrin Pharmaceuticals LLC·Filed 2018·Granted Feb 5, 2019·0 cites·30 claims
- 3550US8247432B2Tripeptidyl peptidase inhibitorsBRESLIN HENRY JOSEPH·Filed 2011·Granted Aug 21, 2012·0 cites·8 claims
- 3646US8394809B2Phenoxy-substituted pyrimidines as opioid receptor modulatorsCOATS STEVEN J·Filed 2010·Granted Mar 12, 2013·0 cites·22 claims
- 3740US10301324B2Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their useAtrin Pharmaceuticals LLC·Filed 2017·Granted May 28, 2019·0 cites·45 claims
- 3839US5294708AGuanidine derivativesMCNEILAB INC·Filed 1993·Granted Mar 15, 1994·1 cites·3 claims
- 3936US6201119B1Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2(thi) onesJANSSEN PHARMACEUTICA NV·Filed 1994·Granted Mar 13, 2001·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Henry J. Breslin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →